-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, many provinces have announced the implementation time of the fifth batch of national procurement
01.
Determine the execution time of 30 provinces
Determine the execution time of 30 provinces
At the end of October, another group of provinces announced the landing date of the fifth batch of centralized procurement
.
Qinghai
Qinghai On October 22, the Qinghai Provincial Medical Security Bureau issued the "Notice on the Implementation of the Fifth Batch of National and Inter-provincial Alliances’ Organization of Drug Centralized Procurement of Selected and Non-selected Varieties", announcing that it will be implemented on October 30, 2021.
The results of the fifth batch of centralized procurement and the Xinjiang Autonomous Region, Chongqing Municipality, and Heilongjiang Provincial Medical Insurance Bureau took the lead in organizing the inter-provincial alliance drug centralized procurement results
.
In addition, the document also pointed out the follow-up arrangements for Shaanxi Province to lead the inter-provincial alliance to organize drug centralized procurement of drugs with the same species selected in the fifth batch of national organizations for centralized procurement of fasudil hydrochloride injection
.
The document shows that if the agreed purchase quantity during the agreement period has been completed, the results of the national procurement with quantity selection will be implemented, and the selected variety of the inter-provincial alliance will be adjusted to the non-selected variety, and the online price shall not be higher than the national selected price; the agreed purchase quantity during the agreement period has not been completed If the inter-provincial alliance is selected, the results of the inter-provincial alliance will still be implemented until the agreed procurement volume is completed
.
Anhui
Anhui On October 19, the Office of the Anhui Provincial Medical Security Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", announcing the implementation of the fifth batch of national procurement from October 25, 2021 Result
.
The document pointed out that the centralized pharmaceutical procurement platform of Anhui Province started to establish a distribution relationship function on October 19, and the selected drug manufacturers should establish an online distribution relationship with the selected distribution company in a timely manner
.
Inner Mongolia
Inner Mongolia On October 19, the Medical Purchasing Center of Inner Mongolia Autonomous Region announced the "Notice on the Implementation of the Fifth Batch of National Centralized Procurement and the Results of the Selection of Drugs Procured in Quantity in Eight Provinces and Two Districts", announcing that the selection will be implemented from 0:00 on October 28, 2021.
Result
.
The document pointed out that the signing of the tripartite agreement will begin on October 25, and requires medical institutions to decompose the agreed purchase volume of each product in the first year to the selected drugs on the Internet when signing the electronic order and sales agreement.
The Autonomous Region Pharmaceutical Collection Center ensures that the selected drugs Payment shall be made within 30 days after the medicine is put into the warehouse
.
Ningxia
Ningxia On October 19, the Ningxia Medical Insurance Bureau issued the "Notice on Implementing the Results of the Fifth Batch of National Organized Drug Centralized Procurement", announcing that it will officially implement the results of the fifth batch of national selection Ningxia on October 30, 2021
.
Jiangsu
Jiangsu On October 14, the Jiangsu Provincial Medical Security Bureau issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", announcing that it will switch the procurement price on the provincial platform at 24:00 on October 25.
Starting at 24:00 on the 31st, the fifth batch of national procurement announced the results of the selection and the addition of incomplete specifications in Jiangsu Province
.
According to Cyber Blue, as of now, 30 provinces have announced the implementation time of the fifth batch of centralized procurement
.
According to the above implementation timetable, 24 provinces have already implemented the fifth batch of centralized procurement, and tomorrow, the results of the fifth batch of centralized procurement in Hunan and Anhui will also be implemented
.
02.
A large number of drugs have been removed from the Internet
A large number of drugs have been removed from the Internet
When the results of the fifth batch of national selections were announced, "CCTV News" reported that it is expected that patients will be able to get reduced-price drugs in October this year
.
The time has entered the end of October, and the implementation time has been determined in most provinces.
At the same time, the arrangements for the unselected drugs are also being advanced
Hebei
Hebei On October 22, the Hebei Provincial Medical Drug Equipment Centralized Procurement Center issued the "Notice on Announcement of the Fifth Batch of National Centralized Procurement of Drugs of the Same Generic Name", which will publish and list the drugs of the same generic name that meet the requirements for listing on the Internet
.
The document pointed out that if the company’s online price in other provinces is lower than the Hebei province’s online price, it should submit a price adjustment application within 30 days.
Provincial network qualification
.
Hubei
Hubei On October 22, the Hubei Province Pharmaceutical Price and Bidding Purchasing Management Service Network issued the "On the Implementation of the Fifth Batch of National-Organized Drug Centralized Procurement and Chongqing, Eqiong, Dianqing, Ningxia New Xinjiang Corps Common Drug Union Procurement (Hubei) non-selected varieties "Notice on Information Declaration and Net Price Adjustment"
.
The document pointed out that the fifth batch of state-organized centralized drug procurement and Chongqing, Eqiong, Dianqingning, New Xinjiang Corps Common Drugs Union (Hubei) non-selected varieties related enterprises need to be in accordance with the requirements from October 22 to October 26.
Net price adjustment
.
Hunan
Hunan On October 22, the Hunan Provincial Public Relations Resource Trading Service Platform issued the "Notice on Doing a Good Job in the Fifth Batch of Nationally Procured and Non-selected Drugs Price Limiting and Linking the Internet
.
"
The document announced the list of the fifth batch of unselected drugs in Hunan Province and the price limit, requiring enterprises to make adjustments as required from October 22 to October 26
.
Hainan
Hainan On October 21, the Hainan Provincial Public Relations Resource Trading Service Center issued the "Notice on the Planning to Withdraw the Network of Some Unselected National Species That Have Not Passed the Consistency Evaluation", announcing that they have passed the quality and efficacy consistency evaluation of the network in Hainan Province.
With more than three drugs (excluding original research drugs and reference preparations), other drugs that have not passed the consistency evaluation of quality and efficacy will be removed from the network
.
The list of drugs to be removed from the network will be publicized, and the publicity period will be until 5 pm on October 25, 2021
.
According to the review, 352 drugs will be removed from the Internet.
In addition, the document requires that companies that have objections to the publicity content should submit an application before the end of the publicity period
.
Jilin
Jilin On October 19, the Jilin Provincial Public Relations Resource Trading Center issued the "Notice on Publicizing the "Fifth Batch" of National Organized Drug Centralized Procurement of Non-selected Original Research or Reference Preparations, and the Results of the Consistency Evaluation of Drug Price Linkage", which announced " The “fifth batch of” countries organized the centralized procurement of non-selected original research or reference preparations, and passed the consistency evaluation of the drug price linkage results
.
The document shows that the publicity period is from October 19th to October 21st at 16:00, and companies that have objections to the publicity results are required to submit an appeal before the end of the publicity period
.
Shaanxi
Shaanxi On October 18, the Shaanxi Provincial Public Resources Trading Center issued the "Announcement on the Price Adjustment Results of the Fifth Batch of Nation-Organized Drug Centralized Procurement of Unselected Drugs", and announced the price adjustment results of the unselected drugs, and announced that the adjustment results will be 2021.
It will be implemented on October 20, 2010
.
At the same time, Shaanxi also announced the removal of drugs whose prices have not been adjusted as required and the removal of drugs from 3 companies that have passed the consistency evaluation.
According to the combing of 793 drugs, they will be removed
.
03.
Reshuffle the market structure
Reshuffle the market structure
The other side of the centralized procurement winning the bid and the substantial increase in product volume is that another batch of drugs will face a substantial reduction in market share, and at the same time, they will have to cut prices or even be forced to withdraw from the network
.
Liu Qian, vice president of AstraZeneca China, who just lost the bid for budesonide suspension in the fifth batch of centralized procurement this year, also said that it is necessary to accelerate the development and listing of innovative drugs, and at the same time expand channels outside centralized procurement to reduce losses
.
According to the relevant regulations of national procurement, if there are more than 3 manufacturers of the same type of medicine that have passed the consistency evaluation, the product that has not passed the consistency evaluation will no longer be selected under the condition of ensuring the supply
.
In addition, affected by the rules for preferential selection of selected products, it is difficult for unselected drugs to enter hospitals compared to selected drugs
.
Under the influence of various factors, a large number of unselected drugs will have to withdraw from the market
.
However, with the continuous improvement of the volume procurement rules, the survival of the unselected products is improving
.
According to the "Notice on Doing a Good Job in the Fifth Batch of Organizations for Centralized Procurement and Use of Drugs in the City" issued by Shanghai Sunshine Pharmaceutical Purchasing Network, it is necessary to take into account stable drug supply and stable clinical use.
Drugs do not adopt the “one size fits all” approach of drug withdrawal and drug withdrawal.
In principle, the proportion of unselected drugs with the same generic name (including dosage forms) is maintained at about 20%
.
Although compared with the selected products, the market share of the unselected drugs is smaller, which is only a drop in the bucket for a large number of unselected companies, but there is a certain degree of protection, which is a positive signal
.
For the unselected companies, continue to seek development space outside the hospital, and strive to win the opportunity to renew the contract in the future, or they will usher in vitality
.
According to the requirements of the "Fourteenth Five-Year" National Medical Insurance Plan, there will be nearly 300 varieties lined up to enter the centralized procurement in the future.